Synthesis, characterization, and properties of amphiphilic chitosan copolymers with mixed side chains by click chemistry

Water-soluble chitosan-g-PMAm (PMAA)-Bodipy probes prepared by RAFT methods for the detection of Fe3+ ion

It is a challenge to achieve the fully water-soluble chitosan. In this work, water-soluble chitosan-based probes were obtained by the following steps: boron-dipyrrolemethene (BODIPY)-OH was synthesized, and then BODIPY-OH was halogenated to BODIPY-Br. Afterwards, BODIPY-Br reacted with carbon disulfide and mercaptopropionic acid to obtain BODIPY-disulfide. BODIPY-disulfide was introduced to chitosan via amidation reaction to obtain fluorescent chitosan-thioester (CS-CTA); it is employed as the macro-initiator. Methacrylamide (MAm) was grafted onto chitosan fluorescent thioester through reversible addition-fragmentation chain transfer (RAFT) polymerization method. Thus, a water-soluble macromolecular probe (CS-g-PMAm) with chitosan as the main chain and PMAm as long-branched chains was obtained. It greatly improved the solubility in pure water. The thermal stability was reduced slightly, and the stickiness was greatly reduced and the samples displayed the characteristics of liquid. CS-g-PMAm could detect Fe³⁺ in pure water. By the same method, CS-g-PMAA (CS-g-Polymethylacrylic acid) was synthesized and investigated as well.

Studies on non-gelatinous & thermo-responsive chitosan with the N-isopropylacrylamide by RAFT methodology for control release of levofloxacin

The non-gelatinous and thermo-responsive properties were introduced in chitosan by incorporating the chain of poly(N-isopropylacrylamide) via reversible addition-fragmentation chain transfer (RAFT) polymerization. To achieve this, the reaction was carried out at 80 °C by modifying the chitosan(CS) with RAFT agent as a macroinitiator (CS-RAFT), where the amine group of CS was protected with phthalic anhydride and then reacted with 4-cyano-4-[(dodecyl sulfanyl thiocarbonyl)sulfanyl]-pentanoic acid (CDSTSP) to form CS-RAFT agent. Further, the addition of NIPAAm chains onto CS-RAFT was carried out in N,N'-dimethylformamide (DMF) solvent by using 2,2'-azobisisobutyronitrile (AIBN) as an initiator in N₂ atmosphere. The controlled addition of NIPAAm chains on to CS was confirmed by ¹H NMR spectroscopy, further, a kinetic study was performed to get the characteristic features of the RAFT reaction. The product was characterized by ¹H NMR, FT-IR, UV-Visible spectroscopy, XRD, SEM, and TGA analyses. The product in aqueous solution showed LCST at 2.0 mg/mL on 33 ± 0.1 °C. Further, beads were prepared with the sodium alginate and loaded the water-soluble levofloxacin drug (60% w/w loading was achieved). The drug delivery process was studied in-vitro at 37 ± 0.1 °C & pH 7.4, which shown controlled release of drug up to 32 h and it was 71% of the loaded levofloxacin.

Actively Targeted Magnetothermally Responsive Nanocarriers/Doxorubicin for Thermochemotherapy of Hepatoma

Nanodrug-delivery systems modified with targeting molecules allow antitumor drugs to localize to tumor sites efficiently. CD147 protein is expressed highly on hepatoma cells. Firstly, we synthesized magnetothermally responsive nanocarriers/doxorubicin (MTRN/DOX) which was composed of manganese zinc (Mn-Zn) ferrite magnetic nanoparticles, amphiphilic and thermosensitivity copolymer drug carriers together with DOX. Then CD147-MTRN/DOX was formed with MTRN/DOX and monoclonal antibody that specifically binds to CD147 protein. It could target hepatoma cells actively and improve the DOX concentration in the tumor sites. Subsequently, an external alternating magnetic field elevated the temperature of the thermomagnetic particles, resulting in structural changes in the thermosensitive copolymer drug carriers, thereby releasing DOX. Hence, CD147-MTRN/DOX could enhance the responsiveness of hepatoma cells to the pre-existing chemotherapy drugs owing to active targeting combined synergistically with thermotherapy and chemotherapy, which has more significant anticancer effects than MTRN/DOX.